DexCom, Abbott withdrew their patent disputes at UPC
MLex Summary: Companies DexCom and Abbott withdrew all claims and counterclaims including revocation actions in their disputes at the Unified Patent Court concerning European patents 3,831,282 and 3,435,866. The UPC Court...To view the full article, register now.
Already a subscriber? Click here to view full article